Navigation Links
Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
Date:3/5/2008

inued operations 218 16,575 (259) 25,813

-------------------------------------------------------------------------

Net earnings (loss) for

the year (13,636) 39,101 (32,296) 33,390

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Net earnings (loss) per

share from continuing

operations

Basic and diluted (0.26) 0.42 (0.61) 0.14

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Net earnings (loss)

per share

Basic (0.26) 0.74 (0.61) 0.64

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Diluted (0.26) 0.74 (0.61) 0.62

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Weighted average number

of shares

Basic 53,182,803 52,694,868 53,182,803 52,099,290

Diluted 53,182,803 53,035,786 53,182,803 52,549,260

Issued and outstanding

shares 53,187,470 53,169,470

(In thousands of US dollars, except share

and per share data)

CONSOLIDATED BALANCE SHEET December December

31, 31,

Unaudited 2007 2006

-------------------------------------------------------------------------

----------------------------------
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
2. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
3. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
4. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
7. AEterna Zentaris Announces Outcome of Managements Strategic Review
8. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
9. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
10. BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
11. MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , ... July 01, 2015 , ... It is now ... (TBI) using single photon emission computed tomography (SPECT) according to researchers from ... which examined over 20,000 brain scans and is believed to be the largest brain ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus ... the development of groundbreaking drugs to treat neurodegenerative ... today that Robert G. Miller , M.D., Director ... Sutter Health,s California Pacific Medical Center in San Francisco, ... Association for $1.5 million to help fund a ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Apex Therapeutics ... BIO International Convention in Philadelphia, PA. , The presentation took place on ... outlined the plans for the development of APX3330 for the treatment of pancreatic cancer. ...
(Date:6/30/2015)... CALGARY , June 30, 2015 /PRNewswire/ - ... ("Shareholders") of common shares of Resverlogix have approved ... to Eastern Capital Limited of 5,600,000 units at ... Private Placement"), each unit being comprised of one ... for aggregate proceeds of approximately CAD$15 million; and ...
Breaking Biology Technology:Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3
... MBF Healthcare,Acquisition Corp. (Amex: MBH ), a ... it and Critical Homecare,Solutions Holdings, Inc. ("CHS"), a ... specialty infusion services, are,scheduled to present on Monday, ... Healthcare Conference in Boston, MA. On February 6, ...
... Campbell Alliance, the leading,management consulting firm specializing ... that Doug Linton has joined its Executive,Advisory ... industry professionals brought,together by Campbell Alliance CEO ... complex engagements. Mr. Linton will focus on,distribution-related ...
... SANTA MONICA, Calif., April 28 Aida,Pharmaceuticals, Inc. (OTC ... data for its Phase 2 testing results of Rh-Apo2L ... The Company,previously announced that the target cancers for the ... The cancer targets,that the Company has chosen are ailments ...
Cached Biology Technology:MBF Healthcare Acquisition Corp. and Critical Homecare Solutions Holdings, Inc. to Present at the 33rd Annual Deutsche Bank Healthcare Conference 2MBF Healthcare Acquisition Corp. and Critical Homecare Solutions Holdings, Inc. to Present at the 33rd Annual Deutsche Bank Healthcare Conference 3Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group 2Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group 3Aida Pharmaceuticals, Inc. Announces Update on Progress of Rh-Apo2L Testing 2
(Date:6/24/2015)... , June 24, 2015 Biometry authentication ... emerging biometric password solution one face in. ... one face in, entering the expanding ... and affordable multifactor-authentication biometric answer to the password ... provided in partnership with KeyLemon, one face in ...
(Date:6/23/2015)... BEACH GARDENS, Fla. , June 23, ... multi-factor identity management and authentication solutions, today announced ... Altus strong, multi-factor authentication solution.  The enhancements ... of use of the DigitalPersona Altus platform ... biometric reader compatibility. In today,s ...
(Date:6/17/2015)... Germany , June 17, 2015 ... Standard: QIA) today launched new Investigator ® STR assay ... the United States . The new genetic ... key genomic markers (short tandem repeats or STRs) for DNA ... evaluate the quality of DNA in each sample, a novel ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
... Over the last forty years, Shigetada Nakanishi has unraveled ... the human nervous system. His work has created ... Today at 2.30 pm he will receive the Gruber ... Diego. In the 2007 Gruber Lecture he will ...
... A recently published research article in the Journal ... Nestl Reserarch Center, Genomatix Software GmbH, Rosetta Inpharmatics ... Molecular Pharmacology Unit demonstrates the synergisms and enhanced ... profiling with the unique and proprietary microarray analysis ...
... Ohio State University have demonstrated that Target Region Amplification ... the important genetic diversity of ornamental flower collections. ... most popular flowers the world. So popular, in fact, ... varieties of geranium in their 2004 distribution catalogue. Sold ...
Cached Biology News:Shigetada Nakanishi receives $500,000 Gruber Neuroscience Prize 2'TRAP' preserves genetic properties of popular geranium 2
Eppendorf tube holder, for Tube rack 175 x 12 mm, 100. Category: Chromatography Systems & Accessories, Systems....
Pooled normal sreum with 0.1% sodium azide as preservative...
Agarose, pulse field, 250 g. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1800 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
100 adhesive strips....
Biology Products: